Cyclooxygenase-2: A novel target for cancer chemotherapy?

Journal of Cancer Research and Clinical Oncology

Volumn 127, Issue 7, 2001, Pages 411-417

  Dempke, Wolfram ^a   Rie, Christoph ^a   Grothey, Axel ^a   Schmoll, Hans Joachim ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Biochemistry; Carcinogenesis; Cyclooxygenase 2; Molecular biology

Indexed keywords

ARACHIDONIC ACID; BASIC FIBROBLAST GROWTH FACTOR; BETA CATENIN; BUTYRIC ACID; CASPASE 3; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; GENE PRODUCT; GROWTH FACTOR; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; NONSTEROID ANTIINFLAMMATORY AGENT; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN; PROTEIN BCL 2; VASCULOTROPIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; CANCER CHEMOTHERAPY; CARCINOGENESIS; COLON MUCOSA; COLON POLYPOSIS; COLORECTAL CANCER; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HYPOXIA; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BETA CATENIN; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; CYTOSKELETAL PROTEINS; ENDOTHELIAL GROWTH FACTORS; ENZYME INHIBITORS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, APC; HUMANS; IMMUNOSUPPRESSION; INFLAMMATION; ISOENZYMES; LYMPHOKINES; MEMBRANE PROTEINS; MUTATION; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; PLATELET-DERIVED GROWTH FACTOR; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RISK FACTORS; TRANS-ACTIVATORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034994651     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320000225     Document Type: Article

References (63)

1. Effect of the cyclooxygenase-2-selective inhibitor NS398 on the secretion of matrix metalloproteinases (MMP-2 and MMP-9) and tissue inhibitors of metalloproteinase (TIMP-1 and TIMP-2) from human prostate tumor cells
2. Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients
3. Pro-apoptotic action of PAR-4 involves inhibition of NF-kappaB activity and suppression of BCL-2 expression
4. Inhibition of lung tumorigenesis by sulindac: Comparison of two experimental protocols
5. Inhibition of lung tumorigenesis by NSAIDS: A working hypothesis
6. Cox-2, iNOS and p53 as play-makers of tumor angiogenesis
7. Differential expression of epidermal growth factor-related proteins in human colorectal tumors
8. A cyclooxygenase-2 (COX-2) selective non-steroidal antiinflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: Regulation of COX-2 by butyrate
9. 2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis
10. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2
11. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
12. Induction of apoptotic cell death in human colorectal carcinoma cell lines by cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drugs: Independence from COX-2 protein expression
13. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal antiinflammatory drug NS-398
14. Prostaglandin H synthase and xenobiotic oxidation
15. Molecular pathology of cyclooxygenase-2 in neoplasia
16. The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines
17. Biology of the adenomatous polyposis coli tumor suppressor
18. The role of cyclooxygenase enzymes in the growth of human-gall bladder cancer cells
19. Regulation of cyclooxygenase-2 and periostin by Wnt-3 in mouse mammary epithelial cells
20. Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines
21. Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions
22. Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis
23. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
24. Aspirin-like molecules that covalently inactivate cyclooxygenase-2
25. 2 inhibits TNF-alpha release via a mechanism involving IL-10
26. Chemopreventive activity of celecoxib, a specific cyclo-oxygenase-2 inhibitor, against colon carcinogenesis
27. Constitutive transcriptional activation by a β-catenin-TCF complex in APC (-/-) colon carcinoma
28. Aspirin induction of apoptosis in esophageal cancer: A potential for chemoprevention
29. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis, and down-regulates bcl-2 expression in LNCaP cells
30. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas
31. Significant roles of inducible cyclooxygenase (COX-2) in angiogenesis in rat sponge implants
32. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants
33. Tumor angiogenesis: The pivotal role of vascular endothelial growth factor
34. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
35. Cyclooxygenase-2 expression inhibits trophic withdrawal apoptosis in nerve growth factor-differentiated PC12 cells
36. Enhancement of tumor response to radiation by an inhibitor of cyclooxygenase-2 enzyme
37. Activation of β-catenin-TCF signaling in colon cancer by mutations in β-catenin or APC
38. Matrix metalloproteinases: Biologic activity and clinical implications
39. A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells
40. 716 knock-out mice by inhibition of cyclooxygenase-2 (Cox-2)
41. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor
42. Self-promotion? Intimate connections between APC and prostaglandin H synthase-2
43. High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion
44. Hypoxia induces cyclooxygenase-2 via NF-kappaB p65 transcription factor in human vascular enothelial cells
45. The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofenac in 2.5% hyluronan
46. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms
47. A selective cyclooxygenase-2 inhibitor suppresses the growth of H-rastransformed rat intestinal epithelial cells
48. Cyclooxygenase-2 induction and transforming growth factor β growth inhibition in rats intestinal epithelial cells
49. 2 in human colon cancer cells
50. Colorectal cancer and nonsteroidal anti-inflammatory drugs
51. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: Evidence of different mechanisms of action
52. Cyclooxygenase-2 inhibitors in tumorigenesis (part II)
53. Immunohistochemical study of cyclooxygenases in prostatic adenocarcinoma: Relationship to apoptosis and bcl-2 protein expression
54. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522
55. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer
56. Caspases and caspase inhibitors
57. Chemopreventive effects of NSAIDs against colorectal cancer: Regulation of apoptosis and mitosis by COX1 and COX-2
58. Inflammation and cancer: Role of phagocyte-generated oxidants in carcinogenesis
59. Cyclooxygenase-2 expression in human colon cancer cell increases metastatic potential
60. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
61. Prostaglandin endoperoxide synthase: Why two isoforms?
62. Cylooxygenase-2 expression in human pancreatic adenocarcinomas
63. Par-4, a proapoptotic gene, is regulated by NSAIDs in human colon carcinoma cells